PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944 | -29.9% | 565 | +0.4% | 0.00% | – |
| Q2 2023 | $1,346 | -23.2% | 563 | +0.5% | 0.00% | – |
| Q1 2023 | $1,753 | +17.0% | 560 | +0.2% | 0.00% | – |
| Q4 2022 | $1,498 | +49.8% | 559 | +0.2% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 558 | -1.4% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 566 | +1.1% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 560 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 560 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -50.0% | 560 | +0.2% | 0.00% | – |
| Q2 2021 | $6,000 | -99.4% | 559 | -99.2% | 0.00% | – |
| Q1 2021 | $1,075,000 | +239.1% | 68,292 | +420.9% | 0.00% | – |
| Q4 2020 | $317,000 | +13.6% | 13,110 | -20.8% | 0.00% | – |
| Q3 2020 | $279,000 | +8.6% | 16,563 | +89.0% | 0.00% | – |
| Q2 2020 | $257,000 | – | 8,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |